轉(zhuǎn)化生長(zhǎng)因子β活化激酶結(jié)合蛋白1抗體 返回列表頁(yè)

轉(zhuǎn)化生長(zhǎng)因子β活化激酶結(jié)合蛋白1抗體

英文名稱 TAB1
中文名稱 轉(zhuǎn)化生長(zhǎng)因子β活化激酶結(jié)合蛋白1抗體
別    名 MAP3K7IP 1; MAP3K7IP1; Mitogen activated protein kinase kinase kinase 7 interacting protein 1; TAB 1; TAK1 binding protein 1; TGF beta activated kinase 1 binding protein 1; TGF-beta activated kinase 1/MAP3K7 binding protein 1; Transforming growth factor beta activated kinase binding protein 1; 2310012M03Rik; 3'-Tab1; MGC57664; TAB1_HUMAN.
 
說(shuō) 明 書 0.1ml  0.2ml  
研究領(lǐng)域 腫瘤  免疫學(xué)  信號(hào)轉(zhuǎn)導(dǎo)  轉(zhuǎn)錄調(diào)節(jié)因子  激酶和磷酸酶  
抗體來(lái)源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 55 kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human MAP3K7IP1/TAB1
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

PubMed PubMed
產(chǎn)品介紹 background:
TAB1 was identified as a regulator of the MAP kinase kinase kinase TAK1/MAP3K7, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta and members of the Toll IL 1R (TIR) superfamily, thus acting as an intermediate in both proliferative and innate and adaptive immune responses. This protein, together with either TAB2 or TAB3, activates TAK1 kinase in response to upstream signals. It has been shown that the C terminal portion of TAB1 is sufficient for binding and activation of TAK1, while a portion of the N terminus acts as a dominant negative inhibitor of TGF beta, demonstrating how this protein can function as a mediator between TGF beta receptors and TAK1.xy-8470R    FBXO36FBXO36 F-box蛋白相關(guān)蛋白36抗體
xy-11345R    ERC2CAST1蛋白抗體
xy-11344R    ERC1RAB6蛋白抗體
xy-11346R    EGFLAM皮卡丘素抗體
xy-11319R    ELAVL4ELAVL4蛋白抗體
xy-11182R    EMR1表皮生長(zhǎng)因子樣激素受體1
xy-3292R    phospho-ERK1 (Thr197 +Thr202)磷酸化絲裂原活化蛋白激酶1/2抗體
xy-0494R    ETFA電子轉(zhuǎn)移黃素蛋白α抗體
xy-8538R    EP4前列腺素E受體蛋白4抗體
xy-0319R    E1 glycoprotein風(fēng)疹病毒糖蛋白抗體
xy-9662R    EFR3AEFR3A蛋白抗體
xy-9660R    ENAHENAH蛋白抗體
xy-7610R    ETHE1乙基丙二酸腦病蛋白抗體
xy-1722R    E2F3轉(zhuǎn)錄因子E2F-3抗體
xy-1734R    E2F5轉(zhuǎn)錄因子E2F-5抗體
xy-1726R    ERCC1DNA切除修復(fù)蛋白1抗體
xy-1750R    E2F6轉(zhuǎn)錄因子E2F6抗體
xy-1751R    EAAT2膠質(zhì)細(xì)胞谷氨酸運(yùn)載蛋白2抗體
xy-1752R    EAAT3膠質(zhì)細(xì)胞谷氨酸運(yùn)載蛋白3抗體(神經(jīng)/上皮細(xì)胞谷氨酸運(yùn)載蛋白)
xy-1753R    ECE2內(nèi)皮素轉(zhuǎn)化酶2抗體
xy-1754R    ECP嗜酸性粒細(xì)胞陽(yáng)離子蛋白抗體
xy-1755R    EGFL7類表皮生長(zhǎng)因子域7抗體
xy-1756R    alpha Elastinα彈性蛋白抗體
xy-2041R    Yellow fever virus envelope glycoprotein E黃熱病毒包膜糖蛋白抗體
xy-1831R    ErbB 2HER2受體抗體
xy-1399R    E2F4轉(zhuǎn)錄因子E2F-4抗體
xy-3104R    Phospho-EGFR (Ser991)磷酸化表皮生長(zhǎng)因子受體抗體
xy-3111R    Phospho-EGFR(Tyr845)磷酸化表皮生長(zhǎng)因子受體抗體
xy-3112R    Phospho-EGFR (Tyr998)磷酸化表皮生長(zhǎng)因子受體抗體
xy-3133R    Phospho-Ezrin (Tyr353)磷酸化埃茲蛋白抗體
xy-3134R    Phospho-Ezrin (Thr567)磷酸化埃茲蛋白抗體